[
    "{\"step_by_step_thinking\": \"Teplizumab is a drug that has been studied for its potential to delay the onset of Type 1 diabetes. In a clinical trial, it was found that teplizumab could delay the onset of Type 1 diabetes in high-risk individuals by approximately two years. Therefore, it does hold promise for diabetes prevention.\", \"answer_choice\": \"A\"}"
]